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ABSTRACT
Functional analysis of multiple genes is key to
understanding gene regulatory networks controlling
embryonic development. We have developed an
integrated vector system for inducible gene
silencing by shRNAmir-mediated RNA interference
in mouse embryos, as a fast method for dissecting
mammalian gene function. For validation of the
vector system, we generated mutant phenotypes
for Brachyury, Foxa2 and Noto, transcription
factors which play pivotal roles in embryonic devel-
opment. Using a series of Brachyury shRNAmir
vectors of various strengths we generated
hypomorphic and loss of function phenotypes
allowing the identification of Brachyury target
genes involved in trunk development. We also dem-
onstrate temporal control of gene silencing, thus by-
passing early embryonic lethality. Importantly,
off-target effects of shRNAmir expression were not
detectable. Taken together, the system allows the
dissection of gene function at unprecedented
detail and speed, and provides tight control of the
genetic background minimizing intrinsic variation.
INTRODUCTION
The mouse is the most widely used mammalian model in
genetic research, due to the availability of inbred strains, a
complete and annotated genome sequence and the ability
to modify the genome by transgenic techniques in embry-
onic stem (ES) cells. Targeted inactivation of gene loci by
homologous recombination or conditional mutagenesis
using site-speciﬁc recombinases are widely applied (1–3).
However, these techniques are time consuming and costly.
RNA interference is a natural mechanism of the cell to
modulate gene function at the mRNA level. The main
endogenous triggers of RNAi are 22-nt single-stranded
RNAs (the so-called microRNAs or miRNAs), which
are transcribed as long precursors from RNA polymerase
II promoters (4). Experimental RNAi employs RNAs that
mimic the structure of miRNA intermediates, such as
short hairpin RNAs (shRNAs) or short hairpin RNAs
in a miRNA context (shRNAmir). RNAi is routinely
used for gene silencing in cellular systems, and is fast
and cost eﬃcient. However, methods for in-vivo RNAi in
the mouse have not yet found wide application (5–9).
We present an integrated transgenic system for
shRNAmir-mediated gene silencing in the mouse. The
system consists of a series of vectors allowing graded
downregulation of gene function and thus, the generation
of mutant phenotypes of various strengths (hypomorphs
to loss of function phenotypes). We demonstrate for the
ﬁrst time the generation of phenocopies of known genetic
null mutants by application of in vivo RNAi in the mouse
embryo. Since our system is inducible, it allows to bypass
early embryonic lethality. In addition, this system controls
for unrelated morphological phenotypes which frequently
arise as a consequence of in vitro manipulation of ES cell
clones. Finally, we show that gene silencing with our
shRNAmir transgene system is achieved virtually
without oﬀ-target eﬀects. Our RNAi toolkit can therefore
provide a ﬂexible and economic alternative to gene
ablation for the analysis of gene function in the mouse.
MATERIALS AND METHODS
Vectors
We inserted the recipient transgene into the XbaI site of
pROSA26-1 and targeted the Gt(ROSA)26Sor locus (10).
The recipient transgene was assembled in pBluescript SK
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30): a SV40 splice acceptor fused to a murinized version of
tTS or rtTA (Clontech) with a SV40 polyadenylation
signal, the 1.2-kb chicken b-globin insulator (50HS4), a
PGK-hygromycin selection cassette ﬂanked by opposing
loxP and lox5171 sites (11,12), and a promoter-less
neomycin resistance gene with bidirectional
polyadenylation signal, followed by another chicken
b-globin insulator. Exchange vectors were assembled in
pBluescript SK and contained the following elements (50
to 30): optimized tetS binding sites (TRE-tight, Clontech),
CAGGS promoter (13), a transgene containing either one
or two shRNAs-mir in a murine mir155 context
(Invitrogen) followed by the thymidine kinase
polyadenylation signal or the coding sequence of EGFP,
one shRNAmir ﬂanked by splice donor and acceptor sites
and the rabbit b-globin polyadenylation signal, the
chicken b-globin core insulator and a PGK promoter
that complements the promoter-less neomycin resistance
gene of the recipient locus upon integration. Exchange
vectors were ﬂanked by loxP and lox5171 sites. Maps
and sequences of the recipient transgene and exchange
vectors are available upon request.
Cell culture and in vitro RNAi
ES cells were cultured in knockout Dulbecco’s Modiﬁed
Eagle’s Medium (Gibco) containing 15% of fetal calf
serum and 1000Uml
 1 LIF (Esgro) according to
standard protocols. We used both C57BL/6 (Shimizu
and Schrewe, unpublished) and G4 ES cells (14) for
Gt(ROSA)26Sor targeting. Clones that had undergone
homologous recombination were identiﬁed by Southern
blot analysis of genomic DNA digested with BamHI,
using a probe external of the 50 Gt(ROSA)26Sor
homology arm, and the neomycin resistance gene as an
internal 30 probe, and termed ROSA26S and ROSA26A.
For RMCE, 3 10
5 ROSA26S or ROSA26A ES cells
were transfected with 5.0mg of exchange vector and
0.1mg of Cre recombinase expression vector using
Lipofectamine 2000 (Invitrogen). Cells were split four
hours after transfection and selected with 250mgml
 1 of
Geneticin (Gibco) starting the following day. Positive re-
combinants were identiﬁed by Southern blot analysis of
genomic DNA digested with HindIII or BamHI/HindIII,
using the neomycin selection cassette as probe. For in vitro
induction, cells were cultured in the presence of 2ngml
 1
doxycycline (Fluka). qRT-PCR was done using
random-hexamer primed cDNA prepared according to
manufacturer protocols (Invitrogen), the Step One Plus
detection system (Applied Biosystems) and SYBR green
(Applied Biosystems). Data were analyzed with Step One
Software v2.1 (Applied Biosystems) using the CT(CT)
method. Per target gene, four individual shRNAmirs in
pCDNA6.2GW/EmGFP miR (Invitrogen) were tested
for interference eﬃcacy by co-transfection with an expres-
sion vector carrying the murine target gene cDNA into
human SW480 cells and subsequent qRT-PCR, as
above. shRNAmirs for in vivo experiments were:
T shRNAmir1 (KD1-T to KD4-T): TGC TGT TAG
TTA GCT CCT TGA AGC GCG TTT TGG CCA
CTG ACT GAC GCG CTT CAG AGC TAA CTA A;
T shRNAmir2 (KD1-T, KD4-T): TGC TGT AGA AGA
TCC AGT TGA CAC CGG TTT TGG CCA CTG ACT
GAC CGG TGT CAT GGA TCT TCT A; Foxa2
shRNAmir1 (KD1-Foxa2): TGC TGT AGG ATG ACA
TGT TCA TGG AGG TTT TGG CCA CTG ACT GAC
CTC CAT GAA TGT CAT CCT A; Foxa2 shRNAmir2
(KD1-Foxa2): TGC TGT GTA CGA GTA GGG AGG
TTT GGG TTT TGG CCA CTG ACT GAC CCA AAC
CTC TAC TCG TAC A; Noto (KD2-Noto): TGC TGT
AAG GTA GCT CTG ATC CTG TGG TTT TGG CCA
CTG ACT GAC CAC AGG ATG AGC TAC CTT A.
Sequences of qRT-PCR primers are available upon
request.
Mice
Fully ES-cell-derived embryos and mice were generated by
tetraploid embryo complementation as previously
described (15). For transgene induction in vivo, doxycyc-
line was administered to mice at 4mgml
 1 in a 1%
sucrose solution in drinking water. For timed induction
intervals, the day of plug was assumed to be E0.5.
Whole-mount in situ hybridization was performed using
protocols and probes described in the MAMEP data-
base (http://mamep.molgen.mpg.de). For northern blot
analysis, whole embryo RNA was isolated in Trizol
(Invitrogen), according to manufacturer’s instructions.
Thirty micrograms RNA/lane were separated on a 15%
denaturing TBE gel and transferred to a GeneScreen Plus
membrane (PerkinElmer). Hybridization was performed
in OligoHyb buﬀer (Ambion) with a
32P-endlabeled oligo-
nucleotide complementary to the predicted siRNA.
Expression proﬁling
For gene expression proﬁling, four independent replicate
proﬁles of each group were prepared. RNAs were isolated
from tissue domains using MinElute columns (Qiagen),
labeled using the MessageAMP Kit (Ambion) and
probes were hybridized to Illumina Sentrix MouseRef-
8v2 miroarrays, according to manufacturer’s instructions.
Expression data was processed using Bead Studio GX
software (Illumina), using the cubic spline normalization
method, and background subtraction. Marginally ex-
pressed genes were removed for analysis by a detection
value cutoﬀ of one in at least four out of eight proﬁles
from the respective tissue domain. Deregulated genes were
selected by more than 2-fold change in expression with a
P-value <0.05 in an unpaired Welch t-test, without
multiple testing correction. Comparison of randomized
expression proﬁles was between 18 sets that contained
equal numbers of proﬁles of induced and noninduced fore-
brains. For analysis of oﬀ-target regulation, Sylamer was
used as suggested by the authors (see www.ebi.ac
.uk/enright/sylamer/sylamer.html). In short, identiﬁers of
expressed genes (detection cutoﬀ as above) in caudal end
or forebrain data sets were ordered by induced versus
non-induced fold change expression. Next, Sylamer
was used to determine the distribution of occurrence of
6-, 7- and 8-mer sequences complimentary to the experi-
mental seeds (shRNAmir 1: TAACTA, AACTAA, TAAC
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shRNAmir2: CTTCTA, TCTTCT, TCTTCTA, ATCTT
CT, GATCTTCT, ATCTTCTA) in these ordered lists,
by analyzing a genome-wide set of murine 30 UTR se-
quences (16).
RESULTS
We decided to establish an integrated vector system with
the following features: (i) single copy transgenes should be
integrated into a deﬁned recipient locus to avoid variabil-
ity caused by the integration site; (ii) the RNAi construct
should be inducible in order to allow temporal control of
RNAi and to control for the integrity of the transgenic ES
cell clones used in the experiments; and (iii) a series of
RNAi vectors for the generation of graded phenotypes
(hypomorphs to loss of function mutants) should be
accommodated.
We modiﬁed ES cells by integrating the tetracycline-
dependent transcriptional silencer (tTS) or the reverse
tetracycline-dependent transcriptional activator (rtTA),
followed by a cassette for recombinase-mediated cassette
exchange (RMCE), into the ﬁrst intron of
Gt(ROSA)26Sor (termed ROSA26S or ROSA26A
recipients). Next, we constructed exchange vectors con-
taining RNAi transgenes compatible with tTS or rtTA
control and the PGK promoter providing G418 resistance
upon successful RMCE (Figure 1A). For tTS-mediated
control of transgene expression we constructed three
exchange vectors containing either two shRNAmir
(KD1), or a single shRNAmir (KD2) or one intronic
shRNAmir and the coding sequence of EGFP (KD3),
driven by the CAGGS promoter. In this setup, tTS is ubi-
quitously expressed under control of the ROSA26
promoter and represses the RNAi constructs until the
block is released by exposure of the cells/embryos to doxy-
cycline. In the rtTA vector system (KD4), the RNAi
vector is silent in the absence of doxycycline and
induced by exposure of the cells/embryos to the drug via
activation of rtTA, which is constitutively expressed from
the ROSA26 locus.
Two eﬃcacious shRNAmir hairpins directed against
Brachyury (T) were identiﬁed in in vitro assays (see
‘Materials and Methods’ section, and Supplementary
Figure S1). T is a T-box transcription factor, which is
essential for embryonic mesoderm formation and noto-
chord development (17). Transient transfection of
ROSA26S or ROSA26A ES cells with exchange vectors
Figure 1. Vector system for inducible RNAi in mouse embryos. (A) Schematic representation of ROSA26A/ROSA26S recipient loci and KD1 to
KD4 exchange vectors used for RNAi. The recipient locus contains either the tTS (for KD1-KD3) or the rtTA (for KD4) gene under control of the
ROSA26 promoter; RNAi exchange vectors are integrated directionally by RMCE using Cre recombinase. Diﬀerent shRNAmir hairpins are
indicated in red and blue. TRE, tTS/rtTA responsive element; SD, SA, splice donor and acceptor sites; ins, chicken globin insulator.
(B) Southern blot analysis of parental and recombined ES cell clones. Positions of probes are indicated in (A). (C) Reversible induction of transgene
expression in vitro. ES cells carrying the KD3-T exchange vector were subjected to cycles of repression ( Dox) and re-induction (+Dox) for 16 days.
Levels of EGFP transgene expression were measured by qRT-PCR. Error bars represent technical replicates.
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produced clones with a complete combined transgene
system (Figure 1B). The addition of doxycycline to the
medium of recombined ES cells led to transgene activa-
tion, which was reversible by doxycycline withdrawal
(Figure 1C).
ES cells containing the vectors KD1-T to KD3-T were
used to generate mouse embryos by tetraploid comple-
mentation (18). Embryos derived from untreated foster
mothers were phenotypically normal (128/128 embryos;
Figure 2A). Embryos derived from foster mothers
exposed to doxycycline in the drinking water, however,
showed various malformations. Embryos expressing
KD1-T (98/98) were indistinguishable from T/T loss of
function mutants (data not shown, see ref. 17). At E9.5,
this phenotype is characterized by absence of the noto-
chord (marked by Shh) caudal to the midbrain, the
absence of allantois derivatives and the presence of few
irregular somites (marked by Uncx) combined with an
excess of neural tissue at the caudal end and early arrest
of posterior development, leading to lethality around E10.
Embryos expressing KD2-T showed either the loss of
function phenotype of KD1-T embryos (18/33) or a
weaker phenotype (15/33): axial elongation had proceeded
up to the tailbud, many though still irregular somites had
formed and the notochord was detectable up to the
forelimb bud. An even milder phenotype was observed
in embryos expressing KD3-T (23/23). Though notochord
Figure 2. Analysis of embryonic phenotypes obtained by RNAi. RNAi constructs are indicated on the top, induction schemes on the bottom of each
panel. (A, C and D) E9.5-10.0 transgenic control embryos ( Dox) or embryos induced for shRNAmir expression (+Dox) targeting T (KD1-T to
KD4-T) or Foxa2 (KD1-Foxa2) gene transcripts were hybridized in situ with T plus Uncx (A, D) or Shh (A, C) speciﬁc probes. Arrowheads mark the
caudal end of the notochord, asterisks mark the endoderm, visualized by Shh transcripts. (B) Fluorescence images of E9.5 KD3-T control ( Dox) or
induced (+Dox) embryos showing ubiquitous EGFP expression. Inserts show bright ﬁeld images. (E) E12.5 control (left) and mutant embryo (right)
induced for RNAi at E9.5 using the rtTA controlled KD4-T construct. Inlays show Shh (upper) or Uncx (lower) expression detected by in situ
hybridization. Arrowheads mark discontinuous Shh expression.
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appeared quite regular in size and number, allantois de-
velopment occurred in some embryos and the caudal end
displayed T transcripts, which were not or hardly detect-
able in KD1-T and KD2-T embryos. Tail outgrowth
failed or was abnormal in all embryos of this series
showing a T RNAi phenotype (Figure 2A). Thus, in
addition to the loss of function phenoype, we were able
to generate embryos with hypomorphic phenotypes, which
are never observed in standard knockout alleles.
We detected enhanced green ﬂuorescent protein
(EGFP) ﬂuorescence throughout the embryos induced
for KD3-T expression, suggesting that the RNAi vector
system can be applied to all tissues (Figure 2B), and found
correct processing of the KD1-T to KD3-T shRNAmirs
(Supplementary Figure S2).
In order to validate the system with additional genes, we
introduced transgenes containing two shRNAmirs
directed against Foxa2 or one shRNAmir against Noto
into ES cells and derived embryos as before. Again,
control embryos for the Foxa2 and Noto models raised
in the absence of doxycycline were phenotypically
normal (9/9 and 13/13, respectively). Induction of the
KD1-Foxa2 shRNAmir resulted in major malformations
in a fraction of embryos (4/11), resembling those described
for Foxa2 loss of function mice (Figure 2C and data not
shown; see also ref. 19). Induced embryos with a
KD2-Noto shRNAmir showed defects in embryonic
turning (2/14), in line with the Noto loss of function
mice, which also show turning defects with incomplete
penetrance (Supplementary Figure S3, see also ref. 20).
We conclude that RNAi via the shRNAmir transgene
system described here is well suited for generating
phenocopies of loss of function as well as hypomorphic
phenotypes in mouse embryos.
Since the induction of transgenes repressed by tTS
during post-implantation development is diﬃcult to
control (unpublished data and ref. 21), for temporally
controlled gene silencing we switched to rtTA, which
provides strong target gene induction with very low back-
ground activity in the noninduced state. ES cells contain-
ing the KD4-T construct comprising two shRNAmir
hairpins directed against T were introduced into
embryos using tetraploid complementation. Noninduced
KD4-T embryos dissected at E9.5 or E12.5 were pheno-
typically normal (17/17 embryos). Embryos induced to
express KD4-T throughout development displayed a
phenotype, which was indistinguishable from E9.5T loss
of function or KD1-T embryos (16/16 embryos;
Figure 2D). However, when KD4-T was induced at E9.5
of development, early lethality was avoided and the
phenotype was conﬁned to the tail. Embryos examined
at E12.5 showed an arrest of mesoderm formation and
notochord development in the mid-tail, indicating that
loss of T function induced by KD4-T RNAi commenced
one day after the doxycycline treatment was initiated (12/
12 embryos; Figure 2E). These results demonstrate the
suitability of the rtTA KD4 vector system for temporally
controlled RNAi in the embryo.
Next, we asked if the speciﬁcity of the KD1-T RNAi
phenotype was also reﬂected by deregulation of genes
involved in the processes controlled by T. To test this,
we analyzed RNA derived from the caudal ends of
KD1-T expressing E8.5 embryos (6–8 somites) using
microarrays. This early stage was chosen since compos-
itional imbalance between mesoderm and neural tissue is
still low. We compared caudal ends from induced versus
noninduced embryos (Figure 3A). Statistical analysis
identiﬁed 37 signiﬁcantly deregulated genes (>2-fold and
P<0.05; 9 up-, 28 down-regulated). Among the
downregulated genes, we found the experimental RNAi
target T, Tbx6 and several markers of the presomitic
mesoderm, as well as the notochord marker Shh
(Figure 3B). These data conﬁrm the speciﬁcity of the
RNAi phenotype generated by KD1-T expression. We
conclude that analysis of RNAi models is suitable for
the functional analysis of genes in embryonic
development.
A major concern when using experimental RNAi is the
occurrence of oﬀ-target eﬀects, i.e. unwanted modulation
of the function of additional mRNAs. To determine if our
experimental embryos show evidence of unspeciﬁc RNA
interference, we analyzed gene expression in the forebrain,
which does not express T, and consequently should not be
aﬀected by KD1-T shRNAmir expression. When we
compared induced versus noninduced forebrains, we
found only three deregulated genes (>2-fold and
P<0.05; 1 up-, 2 downregulated; Figure 3C and D), less
than in comparisons between randomized groups of fore-
brain expression proﬁles (data not shown). We also
determined whether transcripts that contain RNA motifs
complementary to the seed sequence of our experimental
shRNAmirs are underrepresented in the expression
proﬁles, which could be an indicator of oﬀ-target regula-
tion. Using the Sylamer tool (16), we could not detect such
a bias in the genome-wide forebrain or caudal end data
sets (Supplementary Figure S4). Taken together, oﬀ-target
eﬀects were not apparent at the transcriptome level in
embryos induced to express the KD1-T shRNAmir
transgene.
DISCUSSION
In summary, we present a novel single-copy, single-locus
integrated transgenic system for shRNAmir mediated
RNAi in the mouse. By use of this system, we demonstrate
for the ﬁrst time conditional RNAi in the mouse embryo
that phenocopies the genetic null mutant. We present a
panel of vectors allowing the generation of various
hypomorphs of diﬀerent strengths, which have not been
possible to obtain with loss of function alleles. This set of
tools is suitable for investigating the function of genes
playing multiple roles in development in more detail
than previously possible with knockout alleles.
Previously, constitutive high-dosage expression of
shRNA transgenes under control of the H1 RNA poly-
merase III promoter has been used for functional RNAi in
the mouse embryo (5,6). This approach did, however, not
allow direct comparison of induced versus noninduced
control embryos or temporal control over RNAi, and in
some experiments showed more severe phenotypes than
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systems have been used in adult mice (7–9); however, em-
bryonicphenotypeswerenotreported.Aninduciblesystem
in the ROSA26 locus based on high-level expression of
shRNAs under control of RNA polymerase III promoters
has been used to generate a mouse diabetes model (8).
We propose that the system presented here has distinct
advantages in generating null and hypomorphic mutants
with minimal oﬀ-target regulation. In particular, the pos-
sibility to derive genetically identical experimental and
control embryos ensures compatibility with
high-throughput applications, such as expression proﬁling
or massively parallel sequencing.
Modiﬁed exchange vectors may allow tissue-speciﬁc or
multiple gene interference in the future. We provide tTS
and rtTA variants of the system to allow adaptability to a
wide range of applications. In addition, the system can be
applied to various deﬁned genetic backgrounds.
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